Examining biomarkers in patients with acute cerebral hypoxia
Official title: Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia. A Case-control Trial Nested in a Cohort
Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT04971564 · Data updated 2026-11-12
This study is testing the levels of certain inflammation markers in patients with acute brain oxygen loss from conditions like stroke and bleeding in the brain to see how they compare to those without these issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Locations | 1 site (Paris, Île-de-France Region) |
| Status | Recruiting |
| Started | March 19, 2024 |
| Main results expected | June 18, 2028 |
| Study ends | September 18, 2028 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT04971564 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients admitted within 36 hours of acute neurological symptoms related to ischemic stroke, subarachnoid hemorrhage, or intra-parenchymal hematoma.
✕Probably not a fit
Patients with pre-existing disabilities, those under legal protection, pregnant or breastfeeding women, and individuals with secondary hemorrhagic transformation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational trial aims to investigate the levels of thrombo-inflammation biomarkers in patients experiencing acute cerebral hypoxia due to specific conditions such as ischemic stroke, subarachnoid hemorrhage, and intra-parenchymal hematoma. It compares these biomarker concentrations to those in a control group of patients without cerebral hypoxia. Additionally, the study will explore the relationship between biomarker levels and clinical outcomes in patients with cerebral hypoxia. Blood samples will be collected for analysis.
Why it matters
Potential benefit: If successful, this study could enhance understanding of thrombo-inflammation in cerebral hypoxia, potentially leading to improved diagnostic and therapeutic strategies.
How similar studies have gone: While this approach is focused on specific biomarkers in acute cerebral hypoxia, similar studies have shown promise in understanding thrombo-inflammation in other neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- For cases, admitted within the first 36 hours of an acute neurological symptom related to : * An ischaemic cerebrovascular accident (iCVA) eligible for a mechanical thrombectomy procedure, * A subarachnoid haemorrhage (SAH, all aetiologies) : patient presenting with at least a modified Fisher scale 3 or 4, * An intra-parenchymal haematoma (IPH) with greatest axis ≥ 20mm or with NIHSS on admission \>4. OR * For control patients, admitted within 7 days of the onset of acute neurological symptomatology related to a clinical diagnosis of transient ischaemic attack (TIA) - based on thorough questioning of the patient on admission - and prior to imaging, with an ABCD2≥ 2 score. * Express consent to participate in the study. * Member or beneficiary of a social security. Exclusion Criteria: * Pre-existing functional and/or cognitive disability * Patient under legal protection. * Pregnant or breastfeeding woman. * Patient with secondary haemorrhagic transformation. Secondary exclusion criteria : * Patients with an ischaemic lesion visible on imaging, unrelated to large vessel occlusion and therefore ineligible for mechanical thrombectomy. * Patients diagnosed with an acute non-vascular neurological pathology (migraine, epilepsy, etc.). * TIA patients presenting an abnormality on follow-up imaging 24-48 hours after the initial imaging. Excluded patients will be replaced.
Where it's running
-
Hôpital Fondation Adolphe de Rothschild
Paris, Île-de-France Region, France Recruiting
Study contacts
- Study coordinator: François DELVOYE
- Email: fdelvoye@for.paris
- Phone: 0148036556
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
-
Preventing another ischemic stroke with a smart bracelet and app
This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.